Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Ann Cardiothorac Surg. 2013 May;2(3):288-95. doi: 10.3978/j.issn.2225-319X.2013.02.02.
Cerebral protection and circulatory management remains a controversial issue in aortic arch surgery. The present study reported surgical outcomes of arch repair using moderate hypothermic circulatory arrest (MHCA) and unilateral selective antegrade perfusion (uSACP).
From January 2004 and December 2012, 500 patients underwent hemiarch repair (HARCH) and 124 underwent total arch replacement (TARCH) utilizing moderate hypothermic circulatory arrest with unilateral selective antegrade cerebral perfusion of the right axillary artery. Emergent surgery was required in 142 (28.4%) of HARCH patients and 18 (14.5%) of TARCH patients. Mean arrest temperature ranged from 25.6-27.2 °C for elective and emergent operations in both groups. Mean circulatory arrest was 26.8 minutes for hemiarch repairs and 54.2 minutes for total arch replacement.
Overall mortality was 6.6% for hemiarch repairs and 9.7% for total arch replacements. Hospital mortality was 4.5% (16/358) and 10.4% (11/106) in elective cases, and 12% (17/142) and 5.6% (1/18) in elective cases, for hemiarch and total arch replacements respectively. Permanent neurological deficit (PND) occurred in 3 total arch replacement cases (2.4%). Multivariate analysis demonstrated that temperature was not found to be an independent risk factor during hemiarch or total arch replacements for mortality, permanent or neurological deficits, or renal failure.
Our approach for hemiarch and total arch repair utilizing MHCA and uSACP via the right axillary artery was associated excellent neurological and survival outcomes. Moderate hypothermia did not adversely impact cerebral or visceral organ protection.
在主动脉弓手术中,脑保护和循环管理仍然是一个有争议的问题。本研究报告了使用中度低温循环停止(MHCA)和单侧选择性顺行灌注(uSACP)进行弓修复的手术结果。
从 2004 年 1 月至 2012 年 12 月,500 例患者接受了半弓修复(HARCH),124 例患者接受了全弓置换(TARCH),使用中度低温循环停止和右侧腋动脉单侧选择性顺行脑灌注。142 例(28.4%)HARCH 患者和 18 例(14.5%)TARCH 患者需要紧急手术。两组择期和急诊手术的平均停搏温度范围为 25.6-27.2°C。半弓修复的平均循环停止时间为 26.8 分钟,全弓置换的平均循环停止时间为 54.2 分钟。
半弓修复的总死亡率为 6.6%,全弓置换的总死亡率为 9.7%。择期手术的院内死亡率为 4.5%(16/358)和 10.4%(11/106),急诊手术的院内死亡率为 12%(17/142)和 5.6%(1/18),分别用于半弓和全弓置换。3 例全弓置换患者发生永久性神经缺损(PND)(2.4%)。多变量分析表明,在半弓或全弓置换中,温度不是死亡率、永久性或神经功能缺损或肾功能衰竭的独立危险因素。
我们采用 MHCA 和右侧腋动脉的 uSACP 治疗半弓和全弓修复的方法,神经和生存结果良好。中度低温不会对脑或内脏器官保护产生不利影响。